Allergan seeks to expand foot Allergan seeks to expand footprint with retinal therapy print with retinal therapy

New research

CHICAGO — At the Ophthalmology Innovation Summit at AAO, Jag Dosanjhsenior vice president of eye care for Allergan, discusses two new potential treatments for wet age-related macular degeneration and geographic atrophy progressing through clinical trials. Dosanjh also discusses progress in glaucoma and pharmaceutical presbyopia-correcting technology.